USV not dominant player, hence no case: CCI dismisses petition by pharma wholesaler MD bureau24 Feb 2020 1:23 PM ISTNew Delhi: Noting that the drug firm USV does not seem to enjoy the dominant position in the portfolio of medicines that it sells and hence no case...
Novartis, Abbott, Emcure face allegations of cartelisation in anti-diabetes drug Vildagliptin savita thakur thakur26 March 2017 11:33 AM ISTThe Swiss drug maker Novartis and US based Abbott along with domestic companies Emcure and USV Pharma are under the lens of Health Ministry and...